• Polybrene (Hexadimethrine Bromide) 10 mg/mL: Mechanism & Pro

  2026-05-07

  Polybrene (Hexadimethrine Bromide) is a validated viral gene transduction enhancer that improves lentiviral and retroviral delivery by neutralizing cell surface charge. APExBIO's K2701 kit offers a standardized 10 mg/mL solution, supporting reproducible gene transfer and advanced transfection workflows.

• XXLP Modulates NOX2/ROS/Mitochondria/NLRP3 Axis in Ulcerativ

  2026-05-07

  Xu Chunfu’s Modified Xianglian Pill (XXLP) demonstrates anti-inflammatory effects in ulcerative colitis by targeting the NOX2/ROS/mitochondria/NLRP3 signaling axis and modulating gut microbiota. This study integrates proteomics, molecular docking, and microbiome analysis to clarify XXLP’s mechanistic impact and offers translational insights for inflammation research.

• Pifithrin-α: Deep Mechanistic Insights for p53 Inhibition in

  2026-05-06

  Explore the advanced biology of Pifithrin-α as a p53 inhibitor, with a unique focus on its role in ferroptosis and p53-dependent apoptosis inhibition. This article provides novel protocol guidance and critically analyzes recent breakthroughs in neurotoxicity mitigation.

• Cy3 NHS Ester (Non-Sulfonated): Technical Guide for Biomolec

  2026-05-06

  Cy3 NHS ester (non-sulfonated) offers a robust, sensitive solution for labeling primary amines in proteins, peptides, and oligonucleotides, supporting quantitative biomedical imaging with orange fluorescence. It should be selected when organic co-solvent compatibility is acceptable and water-only labeling is not required. For delicate proteins or applications where organic solvents are contraindicated, alternate water-soluble dyes are recommended.

• AMPK’s Dual Role in Autophagy and Energy Stress: New Insight

  2026-05-05

  This study redefines the canonical view of AMPK as a positive regulator of autophagy under energy stress. Using biochemical and genetic approaches, the authors show that AMPK actually inhibits ULK1 activity and autophagy initiation during glucose starvation, while preserving autophagy machinery for future activation. These findings have significant implications for the interpretation of AMPK activation in metabolic research and assay design.

• Dorsomorphin (Compound C): Precision AMPK and BMP Pathway In

  2026-05-05

  Dorsomorphin (Compound C) empowers researchers to selectively dissect AMPK and BMP signaling, enabling robust metabolic, autophagy, and differentiation assays. Discover workflow optimizations, troubleshooting strategies, and direct translational value anchored in recent reference studies.

• Streptavidin-FITC: Advancing Biotin Detection in LNP Traffic

  2026-05-04

  Explore how Streptavidin-FITC enables high-sensitivity biotin detection in advanced lipid nanoparticle trafficking assays. This in-depth review connects molecular mechanism, recent innovations, and practical protocols for maximizing immunofluorescence workflows.

• PtrbZIP12 Regulates Drought Resistance via Phosphorylation P

  2026-05-04

  This study reveals how the bZIP transcription factor PtrbZIP12 enhances drought resistance in Populus trichocarpa by directly activating PtrDHN and PtrPOD genes and highlights the critical role of phosphorylation in this regulatory pathway. These findings inform both plant stress biology and practical approaches for dissecting phosphorylation-dependent mechanisms.

• Cy3-dCTP: Precision Fluorescent Labeling for DNA and cDNA

  2026-05-03

  Cy3-dCTP empowers researchers to directly incorporate robust fluorescent labels into DNA and cDNA with high efficiency, bolstering sensitivity and accuracy for genomics assays. APExBIO’s high-purity Cyanine 3-dCTP is optimized for PCR, Nick Translation, and advanced hybridization workflows, offering seamless integration with modern enzymatic synthesis advances.

• GSK J4 HCl: JMJD3 Inhibitor Elevates Epigenetic Research Imp

  2026-05-02

  GSK J4 HCl streamlines advanced epigenetic regulation research with robust, cell-permeable inhibition of JMJD3. Its compatibility with both in vitro and in vivo models delivers actionable insight into inflammation, chromatin remodeling, and immune modulation workflows.

• Early Life Adversity Impairs Innate Defense via Oxytocin Dis

  2026-05-01

  This study uncovers how early life adversity, modeled as postnatal social deprivation in mice, impairs visually evoked innate defensive behaviors through deficits in oxytocin signaling within the superior colliculus. These findings clarify the neurobiological link between early environmental stress and later susceptibility to impaired fear processing, highlighting oxytocin pathways as a potential therapeutic target.

• Caspase-3/7 Inhibitor I: Precision Tools for Apoptosis Modul

  2026-05-01

  Caspase-3/7 Inhibitor I empowers researchers to dissect and selectively block caspase-dependent apoptosis with high specificity and reversibility. Its proven performance in complex cell models and optimized protocol parameters enable reproducible assays in both infection-driven and cancer research settings.

• Berberine Counters Estrogen Deficiency Bone Loss via Tuft Ce

  2026-04-30

  A recent study demonstrates that berberine ameliorates estrogen deficiency-induced bone loss by promoting the expansion of intestinal tuft cells, mediated by butyrate-GPR41 signaling. These findings highlight the importance of the gut-bone axis and suggest new avenues for managing postmenopausal osteoporosis and inflammatory bone resorption.

• Practical Guide: Cy3 NHS Ester (Non-Sulfonated) for Biomolec

  2026-04-30

  Cy3 NHS ester (non-sulfonated) enables sensitive, specific fluorescent labeling of proteins, peptides, and oligonucleotides by targeting primary amines. It is best suited for workflows where water-insolubility and organic co-solvents are acceptable but should be avoided with delicate proteins requiring aqueous conditions. Proper storage, solvent selection, and workflow controls are essential for reproducible results.

• QPRT Drives Breast Cancer Invasion via P2Y11-Dependent Pathw

  2026-04-29

  This study reveals that quinolinate phosphoribosyltransferase (QPRT) enhances breast cancer cell invasiveness by promoting myosin light chain phosphorylation, primarily through purinergic P2Y11 receptor signaling. Pharmacological inhibition of P2Y11, among other downstream effectors, mitigates QPRT-induced cell migration, highlighting a potential therapeutic axis for metastatic breast cancer.

16145 records 9/1077 page Previous Next First page 上5页 678910 下5页 Last page